National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Indicated for the treatment of adults with nosocomial pneumonia (NP) including ventilator associated pneumomia, known or suspended to be caused by methicillin-resistant Staphylococcus aureas (MRSA).  Vabitiv® should be used only in situations where it is known or suspected that other alternatives are not suitable.

 

Rapid Review

Commenced Completed Outcome
08/12/2014 13/01/2015 Full Pharmacoeconomic Evaluation Not Recommended